Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | VE800 |
| Trade Name | |
| Synonyms | VE-800|VE 800 |
| Drug Descriptions |
VE800 is a mixture comprised of 11 clonally-derived human commensal bacterial strains, which potentially enhances anti-tumor immune responses leading to reduced tumor growth (PMID: 30675064). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C167393 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Nivolumab + Vancomycin + VE800 | Nivolumab VE800 Vancomycin | 0 | 1 |
| unspecified CTLA4 antibody + VE800 | VE800 unspecified CTLA4 antibody | 0 | 0 |
| unspecified PD-1 antibody + VE800 | VE800 unspecified PD-1 antibody | 1 | 0 |
| VE800 | VE800 | 0 | 0 |